Published in Drug Week, January 19th, 2007
In addition, data from 170 studies evaluating Herceptin-based treatment regimens in a variety of settings and disease stages, including preliminary phase II data of Herceptin in combination with Avastin (bevacizumab) in HER2-positive metastatic breast cancer, were presented at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.